Highland Capital Management (Texas)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$514K	Buy	6,000 +3,000	+100%	+$257K	0.03%	251
2019 Q1	$266K	Sell	3,000 -1,500	-33%	-$139K	0.02%	282
2018 Q4	$383K	Buy	4,500 +2,050	+84%	+$195K	0.03%	214
2018 Q3	$238K	Hold	2,450	–	–	0.01%	290
2018 Q2	$231K	Sell	2,450 -13,960	-85%	-$1.22M	0.01%	301
2018 Q1	$1.33M	Buy	16,410 +13,960	+570%	+$1.2M	0.07%	171
2017 Q4	$218K	Hold	2,450	–	–	0.01%	285
2017 Q3	$228K	Hold	2,450	–	–	0.01%	277
2017 Q2	$223K	Hold	2,450	–	–	0.01%	272
2017 Q1	$215K	Sell	2,450 -17,839	-88%	-$1.59M	0.01%	274
2016 Q4	$1.68M	Buy	20,289 +17,839	+728%	+$1.53M	0.08%	149
2016 Q3	$227K	Sell	2,450 -40,000	-94%	-$3.77M	0.01%	289
2016 Q2	$3.3M	Sell	42,450 -73,521	-63%	-$6.25M	0.14%	138
2016 Q1	$9.56M	Buy	+115,971	New	+$9.44M	0.42%	64